SAFETY AND IMMUNOGENICITY OF H3N2 M2SR MONOVALENT INFLUENZA VACCINE ADMINISTERED WITH INACTIVATED FLU VACCINE IN OLDER SUBJECTS
$11,439,843FY2021Defense Health AgencyDOD
Flugen Inc
Investigators
View source on USAspending →SAFETY AND IMMUNOGENICITY OF H3N2 M2SR MONOVALENT INFLUENZA VACCINE ADMINISTERED WITH INACTIVATED FLU VACCINE IN OLDER SUBJECTS · GrantIndex